These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28971841)

  • 1. Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
    Kim HW; Blomkalns AL; Ogbi M; Thomas M; Gavrila D; Neltner BS; Cassis LA; Thompson RW; Weiss RM; Lindower PD; Blanco VM; McCormick ML; Daugherty A; Fu X; Hazen SL; Stansfield BK; Huo Y; Fulton DJ; Chatterjee T; Weintraub NL
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1168-H1179. PubMed ID: 28971841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Paraoxonase Gene Cluster Protects Against Abdominal Aortic Aneurysm Formation.
    Yan YF; Pei JF; Zhang Y; Zhang R; Wang F; Gao P; Zhang ZQ; Wang TT; She ZG; Chen HZ; Liu DP
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):291-300. PubMed ID: 27908891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
    Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOCK2 Deficiency Attenuates Abdominal Aortic Aneurysm Formation-Brief Report.
    Guo X; Cai D; Dong K; Li C; Xu Z; Chen SY
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):e210-e217. PubMed ID: 37021575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
    Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
    Qin Y; Cao X; Guo J; Zhang Y; Pan L; Zhang H; Li H; Tang C; Du J; Shi GP
    Cardiovasc Res; 2012 Dec; 96(3):401-10. PubMed ID: 22871592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.
    Bao W; Morimoto K; Hasegawa T; Sasaki N; Yamashita T; Hirata K; Okita Y; Okada K
    J Vasc Surg; 2014 Apr; 59(4):1098-108. PubMed ID: 23790558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats.
    Yu Z; Morimoto K; Yu J; Bao W; Okita Y; Okada K
    J Vasc Surg; 2016 Sep; 64(3):737-45. PubMed ID: 26070605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.
    Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K
    J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.
    Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
    Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
    J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Inhibition of Cathepsin S Suppresses Abdominal Aortic Aneurysm in Mice.
    Lai CH; Chang JY; Wang KC; Lee FT; Wu HL; Cheng TL
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):990-999. PubMed ID: 32033870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
    Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
    Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoidan attenuates angiotensin II-induced abdominal aortic aneurysms through the inhibition of c-Jun N-terminal kinase and nuclear factor κB activation.
    Tsai SH; Wang JC; Liao WI; Hsu YJ; Lin CY; Liao MT; Huang PH; Lin SJ
    J Vasc Surg; 2018 Dec; 68(6S):72S-81S.e1. PubMed ID: 29290496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
    Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
    Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.